您现在的位置是:首页>肿瘤治疗

美国国家癌症研究院公布抗癌药品清单(囊括所有癌症类型)

2017-11-204508

膀胱癌: Atezolizumab(Tecentriq™) ,nivolumab(Opdivo®) ,durvalumab (Imfinzi™) ,avelumab(Bavencio®) ,  pembrolizumab(Keytruda®)

脑癌: 贝伐单抗(Avastin®),依维莫司(Afinitor®)

乳腺癌: 依维莫司(Afinitor®) ,他莫昔芬(诺瓦得士),托瑞米芬(Fareston®) ,曲妥珠单抗(赫赛汀),氟维司群(FASLODEX) ,阿那曲唑(ARIMIDEX) ,依西美坦(Aromasin®) ,拉帕替尼(TYKERB) ,来曲唑(Femara®) ,帕妥珠单抗(Perjeta®),ADO -曲妥单抗emtansine(Kadcyla®) ,palbociclib(Ibrance®),ribociclib(Kisqali®) ,来那替尼马来酸盐(Nerlynx™) ,abemaciclib(Verzenio™)

宫颈癌: 贝伐单抗(Avastin®)

胃或胃食管交界处腺癌:曲妥珠单抗(赫赛汀® ),雷莫芦单抗(Cyramza®) ,Pembrolizumab(Keytruda)

结肠直肠癌: 西妥昔单抗(爱必妥),帕尼单抗(Vectibix®) ,贝伐单抗,ZIV-阿柏西普(Zaltrap®) ,regorafenib(Stivarga®) ,ramucirumab(Cyramza®),nivolumab(Opdivo®)

皮肤隆突性纤维肉瘤:甲磺酸伊马替尼(Gleevec®)

内分泌/神经内分泌肿瘤: 醋酸兰瑞肽(Somatuline Depot),avelumab(Bavencio)

头和颈癌: 西妥昔单抗(爱必妥),  pembrolizumab(Keytruda®),nivolumab(Opdivo®) 

胃肠道间质瘤: 甲磺酸伊马替尼(Gleevec®),舒尼替尼(Sutent®),瑞格菲尼(Stivarga®)

骨巨细胞瘤: Denosumab(Xgeva®)

肾细胞癌: 贝伐单抗,索拉非尼(多吉美),舒尼替尼 ,帕唑帕尼(Votrient®) ,西罗莫司(TORISEL?) ,依维莫司(Afinitor®) ,阿西替尼(Inlyta®),nivolumab(Opdivo®),  cabozantinib(Cabometyx TM),甲磺酸Lenvatinib(Lenvima)

白血病: 维甲酸(Vesanoid®) ,伊马替尼甲磺酸酯(格列卫),达沙替尼(Sprycel®) ,尼罗替尼(Tasigna®) ,博舒替尼(Bosulif®) ,利妥昔单抗(RITUXAN?) ,阿仑珠单抗(CAMPATH) ,奥法木单抗(Arzerra®),obinutuzumab(Gazyva®) ,依罗替尼(Imbruvica®) ,idelalisib(Zydelig®) ,blinatumomab(Blincyto®),venetoclax(Venclexta™) ,帕纳替尼(Iclusig®) ,米哚妥林(Rydapt®) ,enasidenib甲磺酸酯(Idhifa®) , 奥英妥珠单抗(Besponsa®) ,tisagenlecleucel(Kymriah®) ,吉妥珠单抗(米罗™) ,利妥昔单抗和人透明质酸酶(利妥昔单抗Hycela™)

肝癌: 索拉非尼(Nexavar®),瑞格菲尼(Stivarga®),nivolumab(Opdivo®)

portant; word-wrap: break-word !important;">肺癌: 贝伐单抗,克唑替尼,埃罗替尼,吉非替尼,阿法替尼二马来酸盐,赛尼替尼(LDK378 / Zykadia TM),雷莫芦单抗(),nivolumab( Opdivo®) ,pembrolizumab(Keytruda®),osimertinib(Tagrisso™) ,奈昔(Portrazza™) ,alectinib(Alecensa®),atezolizumab(Tecentriq™) ,brigatinib(Alunbrig™) ,trametinib(Mekinist®),dabrafenib(Tafinlar® )

淋巴瘤: 替伊莫单抗(Zevalin®) ,尼白介素(Ontak®) ,brentuximab vedotin(Adcetris®) ,利妥昔单抗(RITUXAN?) ,伏立诺他(Zolinza®) ,罗米地新(Istodax®) ,贝沙罗汀(TARGRETIN?) ,硼替佐米(万珂®) ,普拉曲沙(Folotyn®),  依罗替尼(Imbruvica®) ,siltuximab(Sylvant®) ,idelalisib(Zydelig®) ,贝林(Beleodaq®) ,obinutuzumab(Gazyva®) ,nivolumab(Opdivo®),pembrolizumab(Keytruda®),利妥昔单抗和透明质酸酶人(Rituxan Hycela TM),盐酸copanlisib(Aliqopa TM),依卡替林(Yescarta TM),acalabrutinib(Calquence)

微卫星不稳定性高或错配修复缺陷的实体瘤:Pembrolizumab(Keytruda)

多发性骨髓瘤: Bortezomib,carfilzomib(Kyprolis), panobinostat(),daratumumab(Darzalex TM),ixazomib柠檬酸盐(Ninlaro),elotuzumab(Empliciti TM) 

骨髓增生异常/骨髓增殖性疾病: 甲磺酸伊马替尼(Gleevec),鲁索替尼磷酸盐(Jakafi)

神经母细胞瘤: Dinutuximab(Unituxin™)

卵巢上皮/输卵管/原发性腹膜癌: Bevacizumab(ovastarb),olaparib(Lynparza TM),rucaparib camsylate(Rubraca TM),niraparib甲苯磺酸盐一水合物(Zejula TM)

胰腺癌: 厄洛替尼(特罗凯),依维莫司(Afinitor®) ,舒尼替尼()

前列腺癌: 卡巴他赛(Jevtana®) ,enzalutamide(Xtandi®) ,阿比特龙乙酸酯(Zytiga®) ,镭223二氯化物(Xofigo®)

皮肤癌:Vismodegib(Erivedge®) ,sonidegib(Odomzo®) ,依匹单抗(Yervoy®),维罗非尼(Zelboraf®) ,trametinib(Mekinist®) ,dabrafenib(Tafinlar®),pembrolizumab(Keytruda®) ,nivolumab(Opdivo®),cobimetinib(Cotellic TM),阿维A酸(Panretin ),avelumab(Bavencio)

软组织肉瘤: Pazopanib,olaratumab(Lartruvo TM),阿利维A酸(Panretin)

胃癌: Pembrolizumab(Keytruda®)

系统性肥大细胞增多症: 甲磺酸伊马替尼(Gleevec®),米哚妥林(Rydapt®)

 

甲状腺癌: Cabozantinib(),凡德他尼(Caprelsa),索拉非尼(Nexavar),甲磺酸仑他替尼(Lenvima)

更多药品信息请登录了解详情。 

紧急通知!如果您有相关基因靶点突变,例如有
EGFR/ALK/NTRK/HER2/claudin18.2/等靶点突变,
请速联系我们,为您申请临床新药,获取营养补助等


1. 添加医学顾问微信,扫描☟二维码
2. 备注【癌种】